
Expected in the first half of 2028, the planned separation would create a stand-alone retail pharmacy company with nearly 30,000 pharmacists.
Joel Wright, chief executive officer, Alliance Rx Walgreens Prime discusses how technology has influenced the way specialty pharmacists manage patient care.



